The value of accessing ophthalmic devices

Analysis

The value of accessing ophthalmic devices through the Prostheses List

Assessing the value of timely treatment

Deloitte Access Economics was commissioned by the Medical Technology Association of Australia to estimate the benefits from accessing ophthalmic devices through the Prostheses List.

In 2017-18, 1.9 million Australians were living with cataract, of whom 110,000 had visual impairment due to cataract. The value of the prostheses list to patients and government was explored by analysing the costs of cataract in Australia using the cost of illness methodology.

Overall, the total financial costs associated with cataract were estimated to be $1.1 billion ($4,430 per surgery) or $2.4 billion including the loss of wellbeing ($9,465 per surgery). The value of timely treatment - the difference in waiting times between the private and public sectors (69 days) - reduced financial and wellbeing costs by an estimated $205.3 million through reducing the number of days lived with untreated cataract.

Published: October 2019

The value of accessing ophthalmic devices through the Prostheses List
  • Contact us
  • Submit RFP
  • Our solutions

    Progress your business growth and development

    Take a look at the products and services we offer.

    Deloitte Access Economics

    Deloitte Access Economics offers a full suite of economic advisory services including economic forecasting, modelling, analysis and advisory services to help our clients plan for the future, understand the implications of major decisions, and navigate the complexities of economic policy.

    Health economics and social policy

    A dedicated practice of professionals with a passion for making an impact in the health and social services sector.

    Health service planning and commissioning

    Deloitte Access Economics offers health service planning and commissioning to help clients match health resources to healthcare needs and unlock improvements in healthcare outcomes for our clients' catchment populations.

  • Our latest reports and thought leadership
Did you find this useful?